Designing, optimizing, and structure prediction of chimeric protein CTB-IpaD for expression in E.coli
dc.contributor.author | Hayat, SMG | |
dc.contributor.author | Sadeghinia, A | |
dc.contributor.author | Elyasifar, B | |
dc.contributor.author | Abbaszadeh-Goudarzi, G | |
dc.contributor.author | Adeli, Z | |
dc.contributor.author | Salimi, S | |
dc.date.accessioned | 2018-08-26T08:51:29Z | |
dc.date.available | 2018-08-26T08:51:29Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53413 | |
dc.description.abstract | The most common cause of diarrhea is Shigella and no vaccine has been found to provide protection against it. IpaD play an important role in invasion, infection, and pathogenesis caused by Shigella. This protein has been one of the most important protein for shigella vaccine candidate. This study aims to link the gene sequence IpaD and CTB with In-silico analysis. Nucleotide sequences were obtained from NCBI database and optimized. Sequences were fused together by a flexible linker in order to find the best epitope exposing chimeric antigen. After Protein half-life and instability index were determined, and then the prediction of the secondary structure and the three-dimensional structure was analyzed and also immunodominant linear B-cell epitopes were also settled at the final step. Codons were changed with respect to codon bias of E.coli and the GC content was changed to an optimal level. Inappropriate structures of RNA were removed. However, these changes led to a prolonged half-life and increased mRNA expression of the recombinant protein. Sequences of the chimeric gene was optimized based on codon usage pattern, In-silico analysis represented that sequence can have a high expression in E.coli and designed to enhance the expression of proteins which contain rare codons at high frequency. (EAAAK) 4 hydrophobic linkers could prevent the domain interactions of the chimeric protein. Chimeric protein can be a good candidate in immunogenicity study to produce an effective vaccine. | |
dc.language.iso | English | |
dc.relation.ispartof | Biosciences Biotechnology Research Asia | |
dc.subject | bacterial protein | |
dc.subject | chimeric protein | |
dc.subject | CTB protein | |
dc.subject | epitope | |
dc.subject | IpaD protein | |
dc.subject | messenger RNA | |
dc.subject | recombinant protein | |
dc.subject | RNA | |
dc.subject | unclassified drug | |
dc.subject | Article | |
dc.subject | B lymphocyte | |
dc.subject | bacterial gene | |
dc.subject | bioinformatics | |
dc.subject | codon usage | |
dc.subject | computer model | |
dc.subject | DNA base composition | |
dc.subject | Escherichia coli | |
dc.subject | gene expression | |
dc.subject | gene sequence | |
dc.subject | half life time | |
dc.subject | immunogenicity | |
dc.subject | nonhuman | |
dc.subject | nucleotide sequence | |
dc.subject | physical chemistry | |
dc.subject | prediction | |
dc.subject | protein expression | |
dc.subject | protein secondary structure | |
dc.subject | protein tertiary structure | |
dc.subject | RNA structure | |
dc.title | Designing, optimizing, and structure prediction of chimeric protein CTB-IpaD for expression in E.coli | |
dc.type | Article | |
dc.citation.volume | 12 | |
dc.citation.spage | 726 | |
dc.citation.epage | 730 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.13005/bbra/2089 |